Zolinza (vorinostat)

vorinostat · Merck & Co.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zolinza (vorinostat), covering 2013-06-24 to 2017-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]